Correlation Between PharmaEngine and Medigen Vaccine

Can any of the company-specific risk be diversified away by investing in both PharmaEngine and Medigen Vaccine at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PharmaEngine and Medigen Vaccine into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between PharmaEngine and Medigen Vaccine Biologics, you can compare the effects of market volatilities on PharmaEngine and Medigen Vaccine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PharmaEngine with a short position of Medigen Vaccine. Check out your portfolio center. Please also check ongoing floating volatility patterns of PharmaEngine and Medigen Vaccine.

Diversification Opportunities for PharmaEngine and Medigen Vaccine

-0.7

Correlation Coefficient

PharmaEngine  Medigen Vaccine

Excellent diversification

The 3 months correlation between PharmaEngine and Medigen is -0.7. Overlapping area represents the amount of risk that can be diversified away by holding PharmaEngine and Medigen Vaccine Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medigen Vaccine Biologics and PharmaEngine is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PharmaEngine are associated (or correlated) with Medigen Vaccine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medigen Vaccine Biologics has no effect on the direction of PharmaEngine i.e., PharmaEngine and Medigen Vaccine go up and down completely randomly.

Pair Corralation between PharmaEngine and Medigen Vaccine

Assuming the 90 days trading horizon PharmaEngine is expected to generate 1.63 times more return on investment than Medigen Vaccine. However, PharmaEngine is 1.63 times more volatile than Medigen Vaccine Biologics. It trades about 0.09 of its potential returns per unit of risk. Medigen Vaccine Biologics is currently generating about -0.24 per unit of risk. If you would invest  8,220  in PharmaEngine on September 12, 2024 and sell it today you would earn a total of  990.00  from holding PharmaEngine or generate 12.04% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

PharmaEngine  vs.  Medigen Vaccine Biologics

PharmaEngine

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in PharmaEngine are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, PharmaEngine showed solid returns over the last few months and may actually be approaching a breakup point.

Medigen Vaccine Biologics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Medigen Vaccine Biologics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in January 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Pair Trading with PharmaEngine and Medigen Vaccine

The main advantage of trading using opposite PharmaEngine and Medigen Vaccine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PharmaEngine position performs unexpectedly, Medigen Vaccine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medigen Vaccine will offset losses from the drop in Medigen Vaccine's long position.

The idea behind PharmaEngine and Medigen Vaccine Biologics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.